FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893215852> ?p ?o ?g. }

• W2893215852 endingPage "199" @default.
• W2893215852 startingPage "192" @default.
• W2893215852 abstract "Liquid-assisted grinding (LAG) and dry ball milling (DBM) have recently been used to obtain different physical forms of drug-amino acid salts with promising dissolution and physical stability properties. In this work, crystalline and co-amorphous naproxen-arginine mixtures were prepared using LAG and DBM, respectively, and compared with regard to their in vitro and in vivo performance. X-ray powder diffraction and Fourier-transformed infrared spectroscopy showed that LAG led to the formation of a crystalline salt, while DBM led to a co-amorphous salt. These results agreed with the differential scanning calorimetry profiles: a melting point of 230 °C was determined for the crystalline salt, while the co-amorphous formulation showed a single glass transition temperature at approx. 92 °C. Both solid state forms of the salt showed increased intrinsic dissolution rates (14.8 and 74.1-fold, respectively) and also higher solubility (25.3 and 29.8-fold, respectively) compared to the pure crystalline drug in vitro. Subsequently, the co-amorphous salt revealed an improved bioavailability in a pharmacokinetic study, showing a 1.5-fold increase in AUC0-t and a 2.15-fold increase in cmax compared to the pure crystalline drug. In contrast, even though showing a better in vitro performance, the crystalline salt interestingly did not show an increase in bioavailability in comparison to pure crystalline naproxen." @default.
• W2893215852 created "2018-10-05" @default.
• W2893215852 creator A5005140480 @default.
• W2893215852 creator A5049090605 @default.
• W2893215852 creator A5050832147 @default.
• W2893215852 creator A5064681095 @default.
• W2893215852 date "2018-11-01" @default.
• W2893215852 modified "2023-10-12" @default.
• W2893215852 title "In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine" @default.
• W2893215852 cites W1480874656 @default.
• W2893215852 cites W1498305210 @default.
• W2893215852 cites W1590254871 @default.
• W2893215852 cites W1773262993 @default.
• W2893215852 cites W1849031002 @default.
• W2893215852 cites W1982785607 @default.
• W2893215852 cites W1985846963 @default.
• W2893215852 cites W1987161794 @default.
• W2893215852 cites W1989433514 @default.
• W2893215852 cites W1992478909 @default.
• W2893215852 cites W1992878295 @default.
• W2893215852 cites W1995662607 @default.
• W2893215852 cites W2001454290 @default.
• W2893215852 cites W2001533174 @default.
• W2893215852 cites W2008844778 @default.
• W2893215852 cites W2040432233 @default.
• W2893215852 cites W2042502385 @default.
• W2893215852 cites W2042824209 @default.
• W2893215852 cites W2046634585 @default.
• W2893215852 cites W2056434768 @default.
• W2893215852 cites W2070311025 @default.
• W2893215852 cites W2075179133 @default.
• W2893215852 cites W2096596459 @default.
• W2893215852 cites W2139221042 @default.
• W2893215852 cites W2169796533 @default.
• W2893215852 cites W2275521990 @default.
• W2893215852 cites W2322472795 @default.
• W2893215852 cites W2322599725 @default.
• W2893215852 cites W2345265433 @default.
• W2893215852 cites W2412248422 @default.
• W2893215852 cites W2419595988 @default.
• W2893215852 cites W2436107268 @default.
• W2893215852 cites W2560479944 @default.
• W2893215852 cites W2756813328 @default.
• W2893215852 cites W2766112955 @default.
• W2893215852 cites W2952528349 @default.
• W2893215852 cites W4243356458 @default.
• W2893215852 doi "https://doi.org/10.1016/j.ejpb.2018.09.024" @default.
• W2893215852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30266670" @default.
• W2893215852 hasPublicationYear "2018" @default.
• W2893215852 type Work @default.
• W2893215852 sameAs 2893215852 @default.
• W2893215852 citedByCount "32" @default.
• W2893215852 countsByYear W28932158522019 @default.
• W2893215852 countsByYear W28932158522020 @default.
• W2893215852 countsByYear W28932158522021 @default.
• W2893215852 countsByYear W28932158522022 @default.
• W2893215852 countsByYear W28932158522023 @default.
• W2893215852 crossrefType "journal-article" @default.
• W2893215852 hasAuthorship W2893215852A5005140480 @default.
• W2893215852 hasAuthorship W2893215852A5049090605 @default.
• W2893215852 hasAuthorship W2893215852A5050832147 @default.
• W2893215852 hasAuthorship W2893215852A5064681095 @default.
• W2893215852 hasConcept C113196181 @default.
• W2893215852 hasConcept C121332964 @default.
• W2893215852 hasConcept C122865956 @default.
• W2893215852 hasConcept C127413603 @default.
• W2893215852 hasConcept C13965031 @default.
• W2893215852 hasConcept C142724271 @default.
• W2893215852 hasConcept C155574463 @default.
• W2893215852 hasConcept C160892712 @default.
• W2893215852 hasConcept C178790620 @default.
• W2893215852 hasConcept C181389837 @default.
• W2893215852 hasConcept C185592680 @default.
• W2893215852 hasConcept C192562407 @default.
• W2893215852 hasConcept C203036418 @default.
• W2893215852 hasConcept C204787440 @default.
• W2893215852 hasConcept C2778115740 @default.
• W2893215852 hasConcept C2909752691 @default.
• W2893215852 hasConcept C39519442 @default.
• W2893215852 hasConcept C42360764 @default.
• W2893215852 hasConcept C43617362 @default.
• W2893215852 hasConcept C521977710 @default.
• W2893215852 hasConcept C56052488 @default.
• W2893215852 hasConcept C60644358 @default.
• W2893215852 hasConcept C71924100 @default.
• W2893215852 hasConcept C86803240 @default.
• W2893215852 hasConcept C88380143 @default.
• W2893215852 hasConcept C97355855 @default.
• W2893215852 hasConceptScore W2893215852C113196181 @default.
• W2893215852 hasConceptScore W2893215852C121332964 @default.
• W2893215852 hasConceptScore W2893215852C122865956 @default.
• W2893215852 hasConceptScore W2893215852C127413603 @default.
• W2893215852 hasConceptScore W2893215852C13965031 @default.
• W2893215852 hasConceptScore W2893215852C142724271 @default.
• W2893215852 hasConceptScore W2893215852C155574463 @default.
• W2893215852 hasConceptScore W2893215852C160892712 @default.
• W2893215852 hasConceptScore W2893215852C178790620 @default.
• W2893215852 hasConceptScore W2893215852C181389837 @default.

• next